Global Cord Blood Corporation
Global Cord Blood Corporation (CORBF) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
corbf · stock forecast · 3 analysts (3M) · FMP · updated Jul 14, 2024
Analyst Rating & Consensus
Based on 3 Wall Street analysts in the past 3 months
Hold
3 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $0.95
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $0.95 | ↓ 0.37% |
1-day model range: $0.94–$0.95. Peak: $0.95 (-0.37%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CORBF · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2016-02-04 | Scotiabank | Downgrade ↓ | Outperform→Sector Perform |
| 2015-08-06 | Jefferies | Maintains | Buy→Buy |
| 2015-06-25 | Roth Capital | Downgrade ↓ | Buy→Neutral |
| 2015-03-17 | Jefferies | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Global Cord Blood Corporation (CORBF) stock. Of the recent 4 rating actions, 0 were upgrades and 2 were downgrades. 3 analysts currently cover CORBF.
Analyst Recommendation Trends
CORBF analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$1.0B
↓ 27.6% YoY
Revenue Next Year
$1.1B
↑ 10.3% YoY
EPS This Year
$3.26
EPS Next Year
$3.08
↓ 5.6% YoY
EPS ForecastReported vs Estimated
Analysts forecast CORBF EPS of $3.26 for the current fiscal year, based on estimates from 1 analysts. The CORBF revenue forecast is $1.0B for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The CORBF stock forecast is supported by two independent data sources: analyst consensus ratings from 3 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus CORBF price target is $0.00 (+0.0% upside), with an analyst consensus of Hold.
The CORBF short-term stock prediction for tomorrow is $0.95 (-0.37%).
Global Cord Blood Corporation trades on OTC under the ticker CORBF. The CORBF stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 33% of covering analysts.
Frequently asked questions
CORBF forecast · 8 questionsAccording to 3 Wall Street analysts, the average 12-month CORBF price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $0.95.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.